As mentioned, GLP-1RAs are increasingly used in the treatment of T2MD owing to their following advantages: lowering of the levels of blood glucose, reducing body weight, improving the function of islet, and exerting potential cardiovascular benefits (206)
Available at: Vicari, E., La Vignera, S., & Calogero, A
Third, medication exposure was based on prescription fills, not direct consumption, which may overestimate the exposure to GLP-1RA and bias estimates, though this is a well-established pharmacoepidemiologic method
When insulin is low, blood sugar rises, Hcy levels increase, cysteine drops, and ATP production slows, causing more ROS and cell damage
All treatments are paid upfront or with buy now, pay later programs